Teduglutide is a glucagon-like peptide-2 (GLP-2) analogue, a naturally occurring hormone that reduces gastric emptying and secretion, and regulates the growth, proliferation and repair of small intestinal endometrial cells. Teduglutide has been approved by several countries for the treatment of patients with short bowel syndrome (SBS) requiring parenteral nutrition support.